iShares MSCI Europe ex-UK UCITS ETF EUR (Dist) CHF is a equity ETF from iShares tracking the MSCI Europe ex-UK index through physical replication. Domiciled in Ireland and launched in 2006, the fund manages about 1.5 bn € and charges a TER of 0.40% — 40 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
iShares MSCI Europe ex-UK UCITS ETF EUR (Dist) CHF competes with 1 other products on the same index (MSCI Europe ex-UK): it ranks 1st by fund size and 2nd by ongoing cost, with a TER of 0.40% against a group median of 0.30%. It has been listed since 2006, 20 years of track record.
On a €10,000 investment the TER costs 40 € a year. The cheapest of the group is Invesco MSCI Europe ex-UK UCITS ETF at 0.20%, or 20 € on the same amount: a difference of 20 € every year, roughly 200 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 24.7% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Ireland, which determines the tax treatment of income received by the fund and the supervisory authority.
| ASML Holding N.V. | 6.9% |
| Roche Holding AG | 2.6% |
| Novartis AG | 2.6% |
| Nestle S.A. | 2.4% |
| Siemens Aktiengesellschaft | 2.2% |
| Banco Santander S.A. | 1.8% |
| Allianz SE VNA O.N. | 1.6% |
| Schneider Electric S.E. | 1.6% |
| ABB Ltd | 1.5% |
| SAP SE | 1.5% |
| Borsa Italiana | IEUX | EUR |
| XETRA | IQQU | EUR |
| Francoforte | IQQU | EUR |
| London Stock Exchange | IEUX | GBX |
| Euronext Amsterdam | IEUX | EUR |
| SIX Swiss Exchange | IEUX | CHF |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.